2025
SJR Q2
JCR Q1 · 5,2
959 matched articles
SCIE
Journal detail
Journal of Drug Delivery Science and Technology
- Publisher
- Editions de Sante
- Country
- France · Western Europe
- Type
- journal
- ISSN
-
1773224725888943
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,78
- Quartile Q2
- H-Index 102
- Cites/doc 5,96
- Docs (3y) 3.107
- Cites (3y) 18.427
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,2
- 5Y JIF 5,3
- JCI 1,22
WoS indexes
- SCIE
Subject classification
Categories (SJR)
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q1 | 0,78 | 5,2 | 5,3 | 1,22 | Q1 | 102 |
| 2024 | Q1 | Q1 | 0,817 | 4,9 | 5,2 | 1,35 | Q1 | 89 |
| 2023 | Q1 | Q1 | 0,719 | 4,5 | 4,7 | 1,36 | Q1 | 89 |
| 2022 | Q1 | Q1 | 0,688 | 5 | 4,7 | 1,34 | Q1 | 89 |
| 2021 | Q1 | Q2 | 0,688 | 5,1 | 4,6 | 1,24 | Q1 | 89 |
| 2020 | Q2 | Q2 | 0,663 | 4 | 3,8 | 1,08 | Q1 | 89 |
| 2019 | Q2 | Q2 | 0,562 | 2,7 | 2,5 | 0,98 | Q2 | 89 |
| 2018 | — | Q2 | — | 2,6 | 2,2 | 0,87 | Q2 | — |
| 2017 | Q2 | Q3 | 0,517 | 2,3 | 1,6 | 0,67 | Q3 | 89 |
| 2016 | Q2 | Q4 | 0,387 | 1,2 | 1,1 | — | — | 89 |
| 2015 | Q2 | Q4 | 0,25 | 0,6 | 0,7 | — | — | 89 |
| 2014 | Q3 | Q4 | 0,251 | 0,5 | 0,7 | — | — | 89 |
| 2013 | Q2 | Q4 | 0,355 | 0,7 | 0,7 | — | — | 89 |
| 2012 | Q2 | Q4 | 0,468 | 1,1 | 0,8 | — | — | 89 |
| 2011 | Q2 | Q4 | 0,332 | 0,7 | 0,6 | — | — | 89 |
| 2010 | Q2 | Q4 | 0,309 | 0,6 | 0,6 | — | — | 89 |
| 2009 | — | Q4 | — | 0,5 | 0,6 | — | — | — |
| 2008 | — | Q4 | — | 0,4 | 0,7 | — | — | — |
| 2007 | — | Q4 | — | 0,7 | 0,7 | — | — | — |
| 2006 | — | Q4 | — | 0,7 | — | — | — | — |
| 2005 | — | Q4 | — | 0,5 | — | — | — | — |
| 2004 | — | — | — | — | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 62/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 48/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 60/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 59/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 75/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 112/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 132/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 133/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 148/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 216/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 236/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 242/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 219/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 203/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 225/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 221/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 217/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 206/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 187/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 180/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 181/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | — | — | — |